Soliton’s RAP Device Received Institutional Review Board Approval of Non-Significant Risk Designation
HOUSTON, TX / ACCESSWIRE / March 8, 2019 / Soliton, Inc., (NASDAQ: SOLY) ("Soliton" or the "Company"), a medical device...
News
Oncolytics Biotech (R) Announces 2018 Year-End Results and Operational Highlights
- Recent biomarker data identifies a simple blood test that may predict clinical response to pelareorep - - AWARE-1 window...
Nephros to Present at the 2019 LD Micro Virtual Conference
LOS ANGELES, CA / ACCESSWIRE / March 7, 2019 / Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company...
NeoGenomics To Present At 39th Annual Cowen and Company Health Care Conference
FT MYERS, FL / ACCESSWIRE / March 7, 2019 / NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic...
Genmed appoints Ruth Billen as finance director
March 7, 2019 – Genmed, a specialist provider of vendor neutral managed services to the NHS, today announces the appointment...
VistaGen Therapeutics to Present at the Cowen and Company 39th Annual Health Care Conference on March 13, 2019
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Parrish Healthcare has Adopted athenahealth Population Health
Parrish Healthcare has Adopted athenahealth Population Health, a National Population Health Management Technology Solution, to Enhance its Certified Integrated Care...
NanoVibronix Reports Positive Interim Tennis Elbow Study Results Using PainShield(R)
70% of patients using PainShield experienced complete resolution or significant improvement in symptoms without the use of opioids PainShield had...
Dynatronics to Attend the American Academy of Orthopaedic Surgeons 2019 Annual Meeting
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 7, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
Cleveland Biolabs Reports 2018 Financial Results and Development Progress
BUFFALO, NY / ACCESSWIRE / March 7, 2019 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development...
Evotec to Attend Upcoming Investor Conferences
HAMBURG, GERMANY / ACCESSWIRE / March 7, 2019 / Evotec AG (FSE: EVT, OTC PINK: EVTCY, MDAX/TecDAX, ISIN: DE0005664809) announced...
Evitrade Subsidiary Closes Joint Venture With Hemp Industry Target In Nevada
VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
CorMedix Inc. to Report Year Ended December 31, 2018 Financial Results on Thursday, March 14
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 7, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Association of Bioscience Financial Officers Introduces Speaker Line-Up for 2019 National Conference Set for May 28-31 in Boston
Association of Bioscience Financial Officers Introduces Speaker Line-Up for 2019 National Conference Set for May 28-31 in Boston BOSTON, MA...
Apogenix Announces Oral and Poster Presentations at Upcoming International Conferences
HEIDELBERG, GERMANY / ACCESSWIRE / March 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
Prevent Announces Completion of Unit Offering
CALGARY, AB / ACCESSWIRE / March 6, 2019 / Prevent Health Care International Corp. (the "Corporation" or "Prevent") today announced...
Certive Announces Expanded Scope of Work with Major Client
Certive Announces Expanded Scope of Work with Major Client and the Closing of its Current Convertible Debt Offering SCOTTSDALE, AZ...
Award Received from the Sexual Medicine Society of North America to Fund a Targazyme TZ101 Study to Reverse Erectile Dysfunction in Prostate Cancer Patients
SAN DIEGO, CA / ACCESSWIRE / March 6, 2019 / Targazyme, a clinical-stage biopharmaceutical company developing novel enzyme products to...
Innovative Medicines Canada Responds to Release of Interim Report of the Advisory Council for the Implementation of National Pharmacare
OTTAWA, ON / ACCESSWIRE / March 6, 2019 / Today's announcement on national pharmacare is an important step forward in...
Pharnext: Reinforcement of Pharnext Equity Capital by Conversion of Convertibles Bonds
PARIS, FRANCE / ACCESSWIRE / March 6, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new...